News

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...
Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks World Hypertension Day 2025 in partnership with Africas ...
Merck Foundation partners with African First Ladies and others to tackle diabetes and hypertension through education and ...
A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...
The CEO of Germany's Merck KGaA on Thursday said a recovery in sales growth at its existing business means it can take a cautious approach to buying other companies, which are expensively priced.
Merck CEO Rob Davis told The Wall Street Journal that this strategic step would ensure that Merck & Co., Inc. (NYSE:MRK) sources its US needs from its US sites. He also said that the company’s ...
Merck Animal Health announced on Thursday morning that it plans to invest $895 million in the expansion of its biologics facility in De Soto.